This page shows results related to Alaway and Dyspnoea from the FDA Adverse Event Reporting System (AERS). The adverse event Dyspnoea has been reported to the FDA a total of 2 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Dyspnoea is 0. The chart below compares this proportional reporting ratio of Dyspnoea for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Dyspnoea.
| Dyspnoea | |
| Alaway | 0 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Dyspnoea, why were they taking Alaway?
| Eye Pruritus | 2 |
Which medications reported to the FDA are most commonly associated with Dyspnoea?
| Vioxx | 6698 |
| Spiriva | 4934 |
| Humira | 3919 |
| Remicade | 3864 |
| Zometa | 3161 |
| Advair Diskus 100/50 | 2437 |
| Enbrel | 2226 |
| Forteo | 2220 |
| Yaz | 2138 |
| Fosamax | 2105 |
| Yasmin | 1944 |
 Show More |
